Re Market Cap Differences- My opinion is that the Market incl institutions use size of proposed 2017/2020 production extended into "back of envelope" value/profit calculations to justify MC comparisons.
There are examples of Institutions investing in UNDER $100mil companies. I have not seen the MNS register of Top 20 showing Institutions taking a Substantial Position when MNS went over $100mil. Yes Holding Companies,Custodial Institutions took Positions but that's not the same.
Anyhow my position is that it's Production forecast that "formulates" Market Cap, in large part especially in pre production stage. With actual production, Revenue and Cost structure "truly" established then all these "proper" FA matrix come in for Institutions etc to work with but til then imo it's just speculation based on bigger is better, isn't it, look on paper.
KNL is on the verge of RoW Debt Financing based on Row Euro and Japan offtakes for ALL of proposed and future expansion production. KNL has valid Ticks indicating late 2017 Producing.
We await the final finance confirmation and then to see what the MC is re rated too.
SYR appears to have it's super pit 2/300kts production 'sorted' by in house value adding to spherical apparently covering [for 75kts] about 140kts or so.plus their 80kts to dragon. but MNS?apparently it's found it needs RoW offtakes for finance and as yet has none. When the get them then they too will face a Finance Delay of months like KNL just has can be presumed.Will their MC hold up at the level during this?
frankly I just don't care but let's hope KNL thread no longer has to suffer the Trolling of the last 6 months from our neighbours.
happy trading
- Forums
- ASX - By Stock
- EGR
- Will KNL go to 48 cents or more?
Will KNL go to 48 cents or more?, page-52
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EGR (ASX) to my watchlist
|
|||||
Last
11.8¢ |
Change
-0.003(2.08%) |
Mkt cap ! $53.34M |
Open | High | Low | Value | Volume |
12.0¢ | 13.0¢ | 11.8¢ | $14.66K | 118.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 150500 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 10553 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 150500 | 0.115 |
8 | 216000 | 0.110 |
9 | 437384 | 0.105 |
15 | 338594 | 0.100 |
1 | 140000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 10553 | 1 |
0.130 | 144240 | 3 |
0.135 | 125399 | 2 |
0.140 | 84519 | 2 |
0.145 | 24910 | 1 |
Last trade - 10.24am 16/07/2024 (20 minute delay) ? |
Featured News
EGR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online